世界中医药

目的：研究乳癖消和乳核散结片对乳腺增生症的治疗作用。方法：采用随机对照前瞻性研究，365名患者分两组，乳癖消片用法为：2.01 g，tid，po，疗程3个月。乳核散结片组用法为4片（1.44 g），tid，po，疗程3个月。两组中治疗无效者进入另一组继续治疗。疗效判定分为四级：临床治愈、显效、有效、无效。停药后跟踪随访半年，观察各个治疗组的疗效。结果：乳癖消片首治者，有效率（临床治愈、显效、有效）为72.22%，无效27.78%；乳核散结片首治者有效率为89.73%，无效10.27%。乳核散结片组的有效率高于乳癖消片组。乳癖消首治无效者服用乳核散结片后有64%的患者有效；而乳核散结片首治无效者服用乳癖消后有57.89%的患者有效。结论：本研究提示乳核散结片是治疗乳腺增生症的一种疗效肯定的较好药物。

English Summary:

To study the therapeutic effects of Rupixiao tablets and Ruhesanjie tablets to treat breast hyperplasia. Methods： Prospective control randomized control trial was conducted, and 365 patients were divided into two groups. Patients in Rupixiao tablets group were given 2.01g，tid，po, for 3 month and Ruhesanjie tablets group applied 1.44g, tid, po, for 3 month. Patients that are non-respond were included into the other group to continue the treatment. The effect was classified to four degrees, including clinical cure, significantly effective, effective, and ineffective. Follow-up was conducted for half a year. The total effective rates of the two groups were observed. Results： The effective rate (clinical cure, significantly effective, effective) of patients first treated with Rupixiao tablets was 72.22%, and inefficacy rate was 27.78%. The effective rate of Ruhesanjie tablets group was 89.73% and the ineffective rate was 10.27%. Sixty four percent of patients who were not responding to Rupixiao tablets showed effect to Ruhesanjie tablets. While 57.89% of patients had effect with Rupixiao tablets when first treated with Ruhesanjie tablets and showed no effect. Conclusion： Ruhesanjie tablets are a good efficacy medicine to treat breast hyperplasia.

查看全文查看/发表评论下载PDF阅读器